
Neuromodulation Device Market Size, Share & Trends Analysis | Global | 2023-2029 | MedCore | Includes: Spinal Cord Stimulation, Deep Brain Stimulation, and 3 more
Description
Neuromodulation Device Market Size, Share & Trends Analysis | Global | 2023-2029 | MedCore | Includes: Spinal Cord Stimulation, Deep Brain Stimulation, and 3 more
The global neuromodulation device market was valued at $4.9 billion in 2022, and is expected to grow at a CAGR of 7.4% during the forecast period to reach $8.2 billion. The market encompasses various segments, such as spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electric stimulation.
MARKET REPORT DATA TYPES INCLUDED
Unit Sales, Average Selling Prices, Market Size & Growth Trends
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
GLOBAL NEUROMODULATION DEVICE MARKET INSIGHTS
One of the primary drivers of the global neuromodulation device market is the continuous technological advancements in neuromodulation devices. An attractive feature for patients is the prolonged battery life in implantable, rechargeable spinal cord stimulation devices. Many manufacturers claim battery lifetimes ranging from five to nine years, and they are currently seeking support from the FDA for longer battery life claims.
GLOBAL NEUROMODULATION DEVICE MARKET SHARE INSIGHTS
Within the global market for neuromodulation devices, there are three key market players – Medtronic, Boston Scientific, Abbott. In 2022, Medtronic was the leading competitor in the global neuromodulation market, offering its InterStim™ therapy system product line. Boston Scientific ranked second in the neuromodulation device market, while Abbott held the third-leading position.
MARKET SEGMENTATION SUMMARY
Global Spinal Cord Stimulation Market
Global Deep Brain Stimulation Market
Global Sacral Nerve Stimulation Market
Global Vagus Nerve Stimulation Market
Global Gastric Electric Stimulation Market
RESEARCH SCOPE SUMMARY
Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast: 2023-2029
Historical Data: 2019-2022
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
WHY CHOOSE IDATA?
Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage– iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing– When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
The global neuromodulation device market was valued at $4.9 billion in 2022, and is expected to grow at a CAGR of 7.4% during the forecast period to reach $8.2 billion. The market encompasses various segments, such as spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electric stimulation.
MARKET REPORT DATA TYPES INCLUDED
Unit Sales, Average Selling Prices, Market Size & Growth Trends
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
GLOBAL NEUROMODULATION DEVICE MARKET INSIGHTS
One of the primary drivers of the global neuromodulation device market is the continuous technological advancements in neuromodulation devices. An attractive feature for patients is the prolonged battery life in implantable, rechargeable spinal cord stimulation devices. Many manufacturers claim battery lifetimes ranging from five to nine years, and they are currently seeking support from the FDA for longer battery life claims.
GLOBAL NEUROMODULATION DEVICE MARKET SHARE INSIGHTS
Within the global market for neuromodulation devices, there are three key market players – Medtronic, Boston Scientific, Abbott. In 2022, Medtronic was the leading competitor in the global neuromodulation market, offering its InterStim™ therapy system product line. Boston Scientific ranked second in the neuromodulation device market, while Abbott held the third-leading position.
MARKET SEGMENTATION SUMMARY
Global Spinal Cord Stimulation Market
Global Deep Brain Stimulation Market
Global Sacral Nerve Stimulation Market
Global Vagus Nerve Stimulation Market
Global Gastric Electric Stimulation Market
RESEARCH SCOPE SUMMARY
Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast: 2023-2029
Historical Data: 2019-2022
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
WHY CHOOSE IDATA?
Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage– iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing– When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Table of Contents
- Neuromodulation Device Market
- 14.1 Executive Summary
- 14.1.1 Global Neuromodulation Device Market Overview
- 14.1.2 Competitive Analysis
- 14.1.3 Markets Included
- 14.1.4 Regions Included
- 14.2 Introduction
- 14.2.1 Spinal Cord Stimulation
- 14.2.2 Deep Brain Stimulation
- 14.2.3 Sacral Nerve Stimulation
- 14.2.4 Vagus Nerve Stimulation
- 14.2.5 Gastric Electric Stimulation
- 14.3 Procedure Numbers
- 14.3.1 Total Neuromodulation Procedures
- 14.3.2 Spinal Cord Stimulation Procedures
- 14.3.3 Deep Brain Stimulation Procedures
- 14.3.4 Sacral Nerve Stimulation Procedures
- 14.3.5 Vagus Nerve Stimulation Procedures
- 14.3.6 Gastric Electric Stimulation Procedures
- 14.4 Market Overview
- 14.4.1 By Segment
- 14.4.2 By Region
- 14.5 Market Analysis and Forecast
- 14.5.1 Total Neuromodulation Device Market
- 14.5.2 Spinal Cord Stimulation Market
- 14.5.3 Deep Brain Stimulation Market
- 14.5.4 Sacral Nerve Stimulation Market
- 14.5.5 Vagus Nerve Stimulation Market
- 14.5.6 Gastric Electric Stimulation Market
- 14.6 Drivers and Limiters
- 14.6.1 Market Drivers
- 14.6.2 Market Limiters
- 14.7 Competitive Market Share Analysis
- LIST OF CHARTS
- Chart 14-1: Neuromodulation Device Market, Global, 2022 & 2029
- Chart 14-2: Neuromodulation Device Procedures, Global, 2022
- Chart 14-3: Total Neuromodulation Procedures by Region, Global, 2019 – 2029
- Chart 14-4: Neuromodulation Device Market by Region, Global, 2019 – 2029
- Chart 14-5: Leading Competitors, Neuromodulation Device Market, Global, 2022
- LIST OF FIGURES
- Figure 14-1: Neuromodulation Device Markets Covered
- Figure 14-2: Neuromodulation Device Regions Covered, Global (1 of 2)
- Figure 14-3: Neuromodulation Device Regions Covered, Global (2 of 2)
- Figure 14-4: Total Neuromodulation Procedures by Region, Global, 2019 – 2029
- Figure 14-5: Total Neuromodulation Procedures by Country, North America, 2019 – 2029
- Figure 14-6: Total Neuromodulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2)
- Figure 14-7: Total Neuromodulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2)
- Figure 14-8: Total Neuromodulation Procedures by Country, Western Europe, 2019 – 2029
- Figure 14-9: Total Neuromodulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)
- Figure 14-10: Total Neuromodulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)
- Figure 14-11: Total Neuromodulation Procedures by Country, Middle East, 2019 – 2029
- Figure 14-12: Total Neuromodulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)
- Figure 14-13: Total Neuromodulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)
- Figure 14-14: Total Neuromodulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)
- Figure 14-15: Total Neuromodulation Procedures by Country, Africa, 2019 – 2029
- Figure 14-16: Spinal Cord Stimulation Procedures by Region, Global, 2019 – 2029
- Figure 14-17: Spinal Cord Stimulation Procedures by Country, North America, 2019 – 2029
- Figure 14-18: Spinal Cord Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2)
- Figure 14-19: Spinal Cord Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2)
- Figure 14-20: Spinal Cord Stimulation Procedures by Country, Western Europe, 2019 – 2029
- Figure 14-21: Spinal Cord Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)
- Figure 14-22: Spinal Cord Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)
- Figure 14-23: Spinal Cord Stimulation Procedures by Country, Middle East, 2019 – 2029
- Figure 14-24: Spinal Cord Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)
- Figure 14-25: Spinal Cord Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)
- Figure 14-26: Spinal Cord Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)
- Figure 14-27: Spinal Cord Stimulation Procedures by Country, Africa, 2019 – 2029
- Figure 14-28: Deep Brain Stimulation Procedures by Region, Global, 2019 – 2029
- Figure 14-29: Deep Brain Stimulation Procedures by Country, North America, 2019 – 2029
- Figure 14-30: Deep Brain Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2)
- Figure 14-31: Deep Brain Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2)
- Figure 14-32: Deep Brain Stimulation Procedures by Country, Western Europe, 2019 – 2029
- Figure 14-33: Deep Brain Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)
- Figure 14-34: Deep Brain Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)
- Figure 14-35: Deep Brain Stimulation Procedures by Country, Middle East, 2019 – 2029
- Figure 14-36: Deep Brain Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)
- Figure 14-37: Deep Brain Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)
- Figure 14-38: Deep Brain Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)
- Figure 14-39: Deep Brain Stimulation Procedures by Country, Africa, 2019 – 2029
- Figure 14-40: Sacral Nerve Stimulation Procedures by Region, Global, 2019 – 2029
- Figure 14-41: Sacral Nerve Stimulation Procedures by Country, North America, 2019 – 2029
- Figure 14-42: Sacral Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2)
- Figure 14-43: Sacral Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2)
- Figure 14-44: Sacral Nerve Stimulation Procedures by Country, Western Europe, 2019 – 2029
- Figure 14-45: Sacral Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)
- Figure 14-46: Sacral Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)
- Figure 14-47: Sacral Nerve Stimulation Procedures by Country, Middle East, 2019 – 2029
- Figure 14-48: Sacral Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)
- Figure 14-49: Sacral Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)
- Figure 14-50: Sacral Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)
- Figure 14-51: Sacral Nerve Stimulation Procedures by Country, Africa, 2019 – 2029
- Figure 14-52: Vagus Nerve Stimulation Procedures by Region, Global, 2019 – 2029
- Figure 14-53: Vagus Nerve Stimulation Procedures by Country, North America, 2019 – 2029
- Figure 14-54: Vagus Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2)
- Figure 14-55: Vagus Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2)
- Figure 14-56: Vagus Nerve Stimulation Procedures by Country, Western Europe, 2019 – 2029
- Figure 14-57: Vagus Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)
- Figure 14-58: Vagus Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)
- Figure 14-59: Vagus Nerve Stimulation Procedures by Country, Middle East, 2019 – 2029
- Figure 14-60: Vagus Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)
- Figure 14-61: Vagus Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)
- Figure 14-62: Vagus Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)
- Figure 14-63: Vagus Nerve Stimulation Procedures by Country, Africa, 2019 – 2029
- Figure 14-64: Gastric Electric Stimulation Procedures by Region, Global, 2019 – 2029
- Figure 14-65: Neuromodulation Device Market by Segment, Global, 2019 – 2029 (US$M)
- Figure 14-66: Neuromodulation Device Market by Region, Global, 2019 – 2029 (US$M)
- Figure 14-67: Neuromodulation Device Market, Global, 2019 – 2029
- Figure 14-68: Units Sold by Region, Neuromodulation Device Market, Global, 2019 – 2029
- Figure 14-69: Average Selling Price by Region, Neuromodulation Device Market, Global, 2019 – 2029 (US$)
- Figure 14-70: Market Value by Region, Neuromodulation Device Market, Global, 2019 – 2029 (US$M)
- Figure 14-71: Spinal Cord Stimulation Market, Global, 2019 – 2029
- Figure 14-72: Units Sold by Region, Spinal Cord Stimulation Market, Global, 2019 – 2029
- Figure 14-73: Average Selling Price by Region, Spinal Cord Stimulation Market, Global, 2019 – 2029 (US$)
- Figure 14-74: Market Value by Region, Spinal Cord Stimulation Market, Global, 2019 – 2029 (US$M)
- Figure 14-75: Deep Brain Stimulation Market, Global, 2019 – 2029
- Figure 14-76: Units Sold by Region, Deep Brain Stimulation Market, Global, 2019 – 2029
- Figure 14-77: Average Selling Price by Region, Deep Brain Stimulation Market, Global, 2019 – 2029 (US$)
- Figure 14-78: Market Value by Region, Deep Brain Stimulation Market, Global, 2019 – 2029 (US$M)
- Figure 14-79: Sacral Nerve Stimulation Market, Global, 2019 – 2029
- Figure 14-80: Units Sold by Region, Sacral Nerve Stimulation Market, Global, 2019 – 2029
- Figure 14-81: Average Selling Price by Region, Sacral Nerve Stimulation Market, Global, 2019 – 2029 (US$)
- Figure 14-82: Market Value by Region, Sacral Nerve Stimulation Market, Global, 2019 – 2029 (US$M)
- Figure 14-83: Vagus Nerve Stimulation Market, Global, 2019 – 2029
- Figure 14-84: Units Sold by Region, Vagus Nerve Stimulation Market, Global, 2019 – 2029
- Figure 14-85: Average Selling Price by Region, Vagus Nerve Stimulation Market, Global, 2019 – 2029 (US$)
- Figure 14-86: Market Value by Region, Vagus Nerve Stimulation Market, Global, 2019 – 2029 (US$M)
- Figure 14-87: Gastric Electric Stimulation Market, Global, 2019 – 2029
- Figure 14-88: Units Sold by Region, Gastric Electric Stimulation Market, Global, 2019 – 2029
- Figure 14-89: Average Selling Price by Region, Gastric Electric Stimulation Market, Global, 2019 – 2029 (US$)
- Figure 14-90: Market Value by Region, Gastric Electric Stimulation Market, Global, 2019 – 2029 (US$M)
- Figure 14-91: Leading Competitors, Neuromodulation Device Market, Global, 2022
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.